Amalgam Rx brings together life sciences companies, payers & providers. By leveraging our +7 Billion RWE data points, creating and distributing exceptional digital medicine products, patient support programs, combination products, and clinical decision support, Amalgam identifies patients in need, increases access, improves adherence, strengthens outcomes, and reduces costs of care. Our team has been reimagining care delivery since before we knew what to call digital health, and creating lasting change across the chronic care ecosystem. Amalgam Rx has built an innovative platform for rapidly developing and scaling digital solutions — delivered through a wide variety of business models. Our proven end-to-end methodology enables the entire life-cycle from R&D to commercialization. Working in partnership with many of the world’s leading life sciences companies and thousands of providers, the Amalgam platform helps millions of patients across 3 continents. For more information on how Amalgam Rx’s FDA-cleared, clinically validated technology transforms data into meaningful actions to unlock value for our partners, visit amalgamrx.com.
Location: United States
Employees: 51-200
Total raised: $26.98M
Founded date: 2016
Investors 3
| Date | Name | Website |
| 15.09.2021 | Plug and P... | plugandpla... |
| - | Venture fo... | venturefor... |
| - | Nanban Ven... | nanbanvent... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.08.2025 | - | $26.98M | Catalio Ca... |
Mentions in press and media 14
| Date | Title | Description |
| 09.01.2026 | Catalio Closes Structured Opportunities Fund II With Over $325 Million For Healthcare Structured Credit | Catalio Capital Management announced it has closed its second credit fund, Catalio Structured Opportunities Fund II, with more than $325 million in commitments across the fund and related co-investment vehicles, exceeding its fundraising ta... |
| 13.08.2025 | Amalgam Rx Secures $20M for AI Healthcare Expansion | Amalgam Rx, a leader in data-driven healthcare, secured a significant $20 million credit investment from Catalio Capital Management. This strategic funding fuels the rapid expansion of its advanced Medical-Grade AI platform. Capital specifi... |
| 12.08.2025 | Amalgam Rx Secures $20M to Accelerate AI-Powered Healthcare Solutions | What You Should Know: – Amalgam Rx, a company specializing in data-driven healthcare decision-making, has announced a $20M credit investment from Catalio Capital Management. – The $20M senior secured term loan provides Amalgam with an initi... |
| 12.08.2025 | Amalgam Rx Raises $20M in Credit Investment from Catalio Capital Management | Amalgam RX, a Wilmington, DE-based company enabling data-driven healthcare decision making, raised £20M in Credit Investment. Catalio Capital Management made the investment. The company intends to use the funds to scale its Medical-Grade AI... |
| 06.10.2023 | Amalgam Rx Receives Investment From CVS Health Ventures | Amalgam Rx, a Wilmington, DE-based company which specializes in enabling data-driven health care decision making, received an investment of undisclosed amount from CVS Health Ventures in its Series B round. The company intends to use the fu... |
| 21.05.2021 | Amalgam Rx Acquires Geetha’s Conversational AI Assets to Drive AI-Based Behavioral and Clinical Interventions | What You Should Know: – Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform has acquired the assets of Geetha, LLC, an adaptive, convers... |
| 25.01.2021 | Wilmington digital health company Amalgam Rx acquired Avhana Health | Wilmington’s Amalgam Rx, a digital medicine and patient support company, has acquired Baltimore-based Avhana Health. With the acquisition, which closed this month, Avhana’s seven employees will join Amalgam’s 100-member team, which already ... |
| 19.01.2021 | Amalgam Rx Announces Acquisition of Avhana Health | Amalgam Rx, Inc., a Wilmington, Del.-based Digital Therapeutics and Patient Support company, acquired Avhana Health, a clinical decision support (CDS) company, which has integrations with electronic health records (EHR). The amount of the d... |
| 15.01.2021 | StartUPDATES: New developments for healthcare startups | ChromaCode has been named a finalist in the XPRIZE Rapid Covid Testing Competition, which aims to increase testing capabilities & accelerate the development of high-quality testing that is low cost, easy to use & quick reporting. Tu... |
| 15.01.2021 | Avhana Health acquired by digital health company Amalgam, Rx | Baltimore-based Avhana Health has been acquired by Amalgam, Rx, a digital medicine and patient support company. With the acquisition, Avhana’s seven employees will join Amalgam’s 100-member team, which is based in Wilmington, Delaware, and ... |
Show more